DESIGN FOR PEPTIDE DELIVERY Trademark

Trademark Overview

On Tuesday, January 6, 2009, a trademark application was filed for DESIGN FOR PEPTIDE DELIVERY with the United States Patent and Trademark Office. The USPTO has given the DESIGN FOR PEPTIDE DELIVERY trademark a serial number of 77643838. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 27, 2017. This trademark is owned by Genzyme Corporation. The DESIGN FOR PEPTIDE DELIVERY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of drug delivery base preformulation screening and optimization
design for peptide delivery

General Information

Serial Number77643838
Word MarkDESIGN FOR PEPTIDE DELIVERY
Filing DateTuesday, January 6, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 27, 2017
Registration Number3808664
Registration DateTuesday, June 22, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical and scientific research in the field of drug delivery base preformulation screening and optimization

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 27, 2017
Primary Code042
First Use Anywhere DateMonday, May 15, 2006
First Use In Commerce DateMonday, May 15, 2006

Trademark Owner History

Party NameGenzyme Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 27, 2017CANCELLED SEC. 8 (6-YR)
Monday, February 8, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 8, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 22, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, August 20, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 20, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 28, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 22, 2010REGISTERED-SUPPLEMENTAL REGISTER
Monday, May 17, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 17, 2010APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, May 14, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 14, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 7, 2010ASSIGNED TO LIE
Monday, May 3, 2010TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, May 3, 2010EX PARTE APPEAL-INSTITUTED
Monday, May 3, 2010JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, May 3, 2010EXPARTE APPEAL RECEIVED AT TTAB
Sunday, November 1, 2009NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, November 1, 2009FINAL REFUSAL E-MAILED
Sunday, November 1, 2009FINAL REFUSAL WRITTEN
Monday, September 28, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 28, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 28, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 24, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 24, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 27, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 27, 2009NON-FINAL ACTION E-MAILED
Friday, March 27, 2009NON-FINAL ACTION WRITTEN
Sunday, March 22, 2009ASSIGNED TO EXAMINER
Friday, January 9, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

delivery peptide design base preformulation screening optimization drug scientific research field medical